stars 1 stars 2 stars 3

ViOptix has developed the proprietary breakthrough T.Ox Tissue Oximetry technology which enables non-invasive, direct, real-time measurement of local tissue oxygen saturation.The key benefit of the T.Ox technology is that it allows physicians, for the first time, to obtain accurate, real-time, direct measurement of tissue oxygen levels which enables them to assess tissue health “on the spot”. Applications of our platform technology, include but are not limited to: • Plastic surgery • Intraoperative and postoperative tissue oxygen saturation monitoring and determination of tissue viability • Estimation of wound healing potential • Peripheral Vascular Disease • Critical Care

ViOptix, Inc. Questions

The ViOptix, Inc. annual revenue was $7 million in 2026.

Mark Lonsinger is the CEO of ViOptix, Inc..

9 people are employed at ViOptix, Inc..

ViOptix, Inc. is based in Newark, California.

The NAICS codes for ViOptix, Inc. are [334, 33].

The SIC codes for ViOptix, Inc. are [38, 384].

Top ViOptix, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users